122 related articles for article (PubMed ID: 15469619)
1. Vaccination of mice with a 30 kDa Schistosoma antigen with and without human adjuvant induces high protection against S. mansoni infection.
Attallah AM; Abdel Aziz MM; Abbas AT; Elbakry KA; El-Sharabasy MM
J Helminthol; 2004 Sep; 78(3):189-94. PubMed ID: 15469619
[TBL] [Abstract][Full Text] [Related]
2. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
Front Immunol; 2018; 9():2488. PubMed ID: 30450095
[TBL] [Abstract][Full Text] [Related]
3. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
Tallima H; Tadros MM; El Ridi R
Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
[TBL] [Abstract][Full Text] [Related]
4. Vaccination against Schistosoma mansoni infection using 74 kDa Schistosoma protein antigen.
Attallah AM; Attia H; Ismail H; Yones E; El-Nashar EM; Abd El-Kader K; Tabll A; Saad A; Sultan A
Vaccine; 1999 Jul; 17(22):2786-91. PubMed ID: 10438048
[TBL] [Abstract][Full Text] [Related]
5. Protective capacity of cercarial transformation fluid alone or in combination with crude cercarial antigen against challenge infections of Schistosoma mansoni in mice.
El Azzouni MZ; Mady RF; Gaafar MR; Arafa FM; Elhadidi A
J Helminthol; 2017 Jan; 91(1):35-42. PubMed ID: 26817577
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity and modulation of granulomatous hypersensitivity in mice using PIII, an anionic fraction of Schistosoma mansoni adult worm.
Hirsch C; Zouain CS; Alves JB; Goes AM
Parasitology; 1997 Jul; 115 ( Pt 1)():21-8. PubMed ID: 9280892
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.
Bungiro RD; Goldberg M; Suri PK; Knopf PM
Infect Immun; 1999 May; 67(5):2340-8. PubMed ID: 10225893
[TBL] [Abstract][Full Text] [Related]
8. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
9. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
Da'Dara AA; Skelly PJ; Walker CM; Harn DA
Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
[TBL] [Abstract][Full Text] [Related]
10. Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).
Zhang W; Ahmad G; Torben W; Siddiqui AA
Acta Trop; 2011 May; 118(2):142-51. PubMed ID: 21334302
[TBL] [Abstract][Full Text] [Related]
11. Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni.
Marques HH; Zouain CS; Torres CB; Oliveira JS; Alves JB; Goes AM
Immunobiology; 2008; 213(5):437-46. PubMed ID: 18472052
[TBL] [Abstract][Full Text] [Related]
12. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
13. Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum.
Argiro L; Henri S; Dessein H; Dessein AJ; Bourgois A
Vaccine; 1999 Jan; 17(1):13-8. PubMed ID: 10078602
[TBL] [Abstract][Full Text] [Related]
14. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
[TBL] [Abstract][Full Text] [Related]
15.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni in the baboon: modulation of pathology after vaccination with polyclonal anti-idiotypic antibodies.
Nyindo M; Borus PK; Farah IO; Oguya FO; Makawiti DW
Scand J Immunol; 1995 Dec; 42(6):637-43. PubMed ID: 8552987
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
[TBL] [Abstract][Full Text] [Related]
19. Protective immunization of mice against Schistosoma mansoni with purified adult worm surface membranes.
Smithers SR; Hackett F; Ali PO; Simpson AJ
Parasite Immunol; 1989 Jul; 11(4):301-18. PubMed ID: 2476710
[TBL] [Abstract][Full Text] [Related]
20. A Survey on the Adjuvant Role of Naloxone Alone or Combined with Alum in Vaccination Against Fasciolosis in BALB/c Mice.
Azizi H; Mirzaeei H; Bagheri A; Bazi A; Khamesipour A; Yaghoobi H; Mirzapour A; Khatami M; Elikaee S
Acta Parasitol; 2019 Jun; 64(2):236-245. PubMed ID: 30788648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
